Full text
=========

Introduction
------------

The pulmonary microvascular hydrostatic or effective capillary pressure (PCP~eff~) is the principal determinant of the rate of edema formation \[[@B1],[@B2]\]. Since scarce data are available only on the natural development PCP~eff~, of independently from vasoactive treatment, we investigated the time course of both PCP~eff~ and the longitudinal distribution of pulmonary vascular resistance during long-term hyperdynamic porcine endotoxemia.

Methods
-------

Over 9 h anesthetized and ventilated pigs received continuous intravenous endotoxin (ETX, n=7) or placebo (Sham, n=5). Hydroxyethylstarch was infused to maintain MAP \> 65 mmHg together with a sustained 30--50% increase in cardiac output. Mean (MPAP) and pulmonary artery occluded (PAOP) pressures were recorded before and 3, 6, and 9 h after the start of ETX. After signal filtering via a low-pass filter, PCP~eff~ was derived from a bi-exponential fit to the post-occlusion pressure decay curve, back-extrapolating the slower part to the instant of occlusion determined by simultaneously recording the balloon pressure \[[@B1]\]. The contribution of the venous resistance to the pressure drop over the pulmonary vascular bed was calculated as PVR~ven~=(PCP~eff~-PAOP)/(MPAP-PAOP) \[[@B1]\].

Results
-------

See [Table](#T1){ref-type="table"}.

Conclusion
----------

Early endotoxemia results in a pronounced increase of PCP~eff~ both due to increased downstream (i.e.left atrial) pressure as well as increased contribution of the postcapillary pressure drop. Hypoxia and/or early mediator release (i.e. thromboxane) probably assume importance in this context \[[@B1]\]. The later normalization of both PCP~eff~ and PVR~ven~ may be due to increased NO formation \[[@B3]\].

                    Before ETX   3 h ETX            6 h ETX            9 h ETX
  ---------- ------ ------------ ------------------ ------------------ ------------------
  MPAP       ETX    22 (18/23)   47 (42/52)\#^\*^   44 (41/52)\#^\*^   34 (32/35)\#^\*^
  mmHg       Sham   19 (17/22)   19 (18/21)         22 (20/25)         22 (21/23)
  PAOP       ETX    7 (5/10)     11 (10/13)\#^\*^   9 (7/12)           8 (7/11)
  mmHg       Sham   6 (4/7)      6 (5/7)            5 (4/5)            6 (5/7)
  PCP~eff~   ETX    10 (8/11)    24 (20/26)\#^\*^   17 (11/24)^\*^     14 (12/16)
  mmHg       Sham   8 (6/9)      7 (6/7)            8 (6/8)            9 (7/10)
  PVR~ven~   ETX    23 (21/27)   37 (34/39)^\*^     24 (23/27)         22 (19/26)
  \%         Sham   19 (18/22)   15 (11/18)         16 (15/19)         16 (14/20)

Median (25/75%), \# *P*\< 0.05 vs 0h (Friedman-Anova); ^\*^*P*\< 0.05 ETX vs Sham (Mann-Whitney)
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